TY - JOUR
T1 - Determinants of population changes in fibrinogen and factor vii over 6 years
T2 - The Atherosclerosis Risk in Communities (ARIC) study
AU - Folsom, Aaron R.
AU - Wu, Kenneth K.
AU - Rasmussen, Mandy
AU - Chambless, Lloyd E.
AU - Aleksic, Nena
AU - Nieto, F. Javier
PY - 2000/2
Y1 - 2000/2
N2 - Although numerous cross-sectional studies have identified possible determinants of plasma fibrinogen and factor VII levels, few prospective studies exist. We assessed the longitudinal relation of changes in fibrinogen and factor VII over 6 years with changes to other cardiovascular risk factors in a sample of 440 men and 549 women from the Atherosclerosis Risk in Communities (ARIC) study. Fibrinogen increased more in older participants, those with or who developed diabetes, those who at any time smoked, and those whose plasma HDL cholesterol or triglycerides decreased and increased less in female participants who started hormonal replacement therapy. Factor VII coagulant activity increased more in younger participants, women, those who gained greater weight or developed diabetes, those who quit smoking, those in whom plasma triglycerides decreased, and female participants who received hormonal replacement therapy. Thus, our longitudinal data suggest with some exceptions that adverse changes in cardiovascular risk factors are accompanied by increases in plasma levels of fibrinogen and factor VII.
AB - Although numerous cross-sectional studies have identified possible determinants of plasma fibrinogen and factor VII levels, few prospective studies exist. We assessed the longitudinal relation of changes in fibrinogen and factor VII over 6 years with changes to other cardiovascular risk factors in a sample of 440 men and 549 women from the Atherosclerosis Risk in Communities (ARIC) study. Fibrinogen increased more in older participants, those with or who developed diabetes, those who at any time smoked, and those whose plasma HDL cholesterol or triglycerides decreased and increased less in female participants who started hormonal replacement therapy. Factor VII coagulant activity increased more in younger participants, women, those who gained greater weight or developed diabetes, those who quit smoking, those in whom plasma triglycerides decreased, and female participants who received hormonal replacement therapy. Thus, our longitudinal data suggest with some exceptions that adverse changes in cardiovascular risk factors are accompanied by increases in plasma levels of fibrinogen and factor VII.
KW - Diabetes mellitus
KW - Factor VII
KW - Fibrinogen
KW - Studies, prospective
UR - http://www.scopus.com/inward/record.url?scp=0033952057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033952057&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.20.2.601
DO - 10.1161/01.ATV.20.2.601
M3 - Article
C2 - 10669661
AN - SCOPUS:0033952057
SN - 1079-5642
VL - 20
SP - 601
EP - 606
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 2
ER -